![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 38, 35760-35765, September 20, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Phospholipase C-
Phospholipase C-
Modulates Epithelial Tight
Junction Permeability through Hyperphosphorylation of Tight Junction
Proteins*
,
, and
§**
Department of Pharmacology, School of
Medicine, University of North Carolina, Chapel Hill, North Carolina
27599, § Division of Drug Delivery and Disposition, School
of Pharmacy, University of North Carolina, Chapel Hill, North
Carolina 27599, ¶ GlaxoSmithKline, Research Triangle Park, North
Carolina 27709, and
Quality Chemical Laboratories,
Wilmington, North Carolina 28405
(PLC-
) is
stimulated by epidermal growth factor via activation of the
epidermal growth factor receptors. The PLC inhibitor, 3-nitrocoumarin
(3-NC), selectively inhibited PLC-
in Madin-Darby canine kidney
cells without affecting the activity of PLC-
. In contrast,
inhibitors of PLC-
, hexadecylphosphocholine and U73122, had no
effect on the activity of PLC-
. Inhibition of PLC-
by 3-NC was
associated with an increase in tight junction permeability across
Madin-Darby canine kidney cell monolayers, as evidenced by 3-NC-induced
decrease in transepithelial electrical resistance and increase in
mannitol flux over a concentration range that was inhibitory to
PLC-
. An analog of 3-NC, 7-hydroxy-3-NC (7-OH-3-NC), which was
inactive as an inhibitor of PLC-
, also had no effect on tight
junction permeability. Treatment with 3-NC caused punctate disruption
in the cortical actin filaments. The PLC-
inhibitor, 3-NC, but not
the inactive analog, 7-OH-3-NC, caused hyperphosphorylation of the
tight junction proteins, occludin, ZO-1, and ZO-2. The serine/threonine
kinase inhibitor, staurosporine (50-200 nM),
significantly attenuated 3-NC-induced hyperphosphorylation of ZO-2.
This corresponded with attenuation by staurosporine of 3-NC-induced
increase in tight junction permeability, suggesting a relationship
between ZO-2 phosphorylation and tight junction permeability.
*
This work was supported by PhRMA Foundation in the form of a
Predoctoral Fellowship (to P. W.) and by GlaxoWellcome
(unrestricted gift).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
This article has been cited by other articles:
![]() |
T. Suzuki, A. Seth, and R. Rao Role of Phospholipase C{gamma}-induced Activation of Protein Kinase C{epsilon} (PKC{epsilon}) and PKC{beta}I in Epidermal Growth Factor-mediated Protection of Tight Junctions from Acetaldehyde in Caco-2 Cell Monolayers J. Biol. Chem., February 8, 2008; 283(6): 3574 - 3583. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K Singh, Y. Jiang, S. Gupta, and E. Benlhabib Effects of chronic ethanol drinking on the blood brain barrier and ensuing neuronal toxicity in alcohol-preferring rats subjected to intraperitoneal LPS injection Alcohol Alcohol., September 1, 2007; 42(5): 385 - 399. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Kiryushko, V. Novitskaya, V. Soroka, J. Klingelhofer, E. Lukanidin, V. Berezin, and E. Bock Molecular Mechanisms of Ca2+ Signaling in Neurons Induced by the S100A4 Protein. Mol. Cell. Biol., May 1, 2006; 26(9): 3625 - 3638. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Stamatovic, O. B. Dimitrijevic, R. F. Keep, and A. V. Andjelkovic Protein Kinase C{alpha}-RhoA Cross-talk in CCL2-induced Alterations in Brain Endothelial Permeability J. Biol. Chem., March 31, 2006; 281(13): 8379 - 8388. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Jun, R. A. Fratti, and W. Wickner Diacylglycerol and Its Formation by Phospholipase C Regulate Rab- and SNARE-dependent Yeast Vacuole Fusion J. Biol. Chem., December 17, 2004; 279(51): 53186 - 53195. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. D. Ward, H. Ouyang, and D. R. Thakker Role of Phospholipase C-{beta} in the Modulation of Epithelial Tight Junction Permeability J. Pharmacol. Exp. Ther., February 1, 2003; 304(2): 689 - 698. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |